83492-16-4Relevant academic research and scientific papers
Facile syntheses of functionalized toll-like receptor 7 agonists
Akinbobuyi, Babatope,Byrd, Matthew R.,Chang, Charles A.,Nguyen, Mysa,Seifert, Zacharie J.,Flamar, Anne-Laure,Zurawski, Gerard,Upchurch, Katherine C.,Oh, Sangkon,Dempsey, Stephen H.,Enke, Thomas J.,Le, John,Winstead, Hunter J.,Boquín, José R.,Kane, Robert R.
supporting information, p. 458 - 460 (2015/04/27)
Protein conjugates of toll-like receptor 7 agonists have been shown to elicit powerful immune responses. In order to facilitate our studies in this area our group has developed efficient syntheses for a number of functionalized derivatives that retain imm
Synthesis and biological evaluation of 2,8-disubstituted 9-benzyladenines: Discovery of 8-mercaptoadenines as potent interferon-inducers
Hirota, Kosaku,Kazaoka, Kazunori,Sajiki, Hironao
, p. 2715 - 2722 (2007/10/03)
Recently, we have identified 9-benzyl-8-hydroxyadenines bearing an appropriate substituent (a butoxy, propylthio or butylamino group) at the 2-position as potent interferon (IFN)-inducers. Herein we report the design, synthesis, and IFN-inducing activity of 8-substituted 9-benzyladenines possessing such an appropriate substituent at the 2-position. Introduction of the appropriate substituent into the 2-position of the adenine nucleus gave rise to expression of the activity even in 9-benzyladenines bearing no hydroxyl group at the 8-position. An amino group at the 6-position and a hydroxyl or thiol group carrying an acidic proton at the 8-position are required to express excellent IFN-inducing activity. 9-Benzyl-2-butoxy-8-mercaptoadenine (9) indicated the most potent activity with MEC of 0.001 μM.
Heterocyclic compounds
-
, (2008/06/13)
The present invention relates to a heterocyclic compound of the following general formula (I): wherein X is sulfur atom, oxygen atom or —NR3— (R3may form a heterocyclic ring or a substituted heterocyclic ring with R1via the nitrogen atom), R1is alkyl group, substituted alkyl group, aryl group, substituted aryl group, heterocyclic group or substituted heterocyclic group, and R2is hydrogen atom, halogen atom etc.; or its pharmaceutically acceptable salt and interferon inducers, antiviral agents, anticancer agents and therapeutic agents for immunologic diseases comprising the compound (I) or its pharmaceutically acceptable salt as active ingredients.
